# Specification Quality Checklist: Autoimmune Disease Rules (user's Google Drive guide)

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-11-11
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- **The project's own spec convention names engine owners.** Rule ids (`ana_family_result`, `rf_positive`) and N-references appear in Current Behaviour and in FR-002/FR-003 on purpose. This follows specs/021–022: the duplicate table must name the owner, or a duplicate rule gets written. The requirements themselves state behaviour (what the patient sees), not code structure.
- **Scope was decided without asking**, and is recorded in Assumptions. In scope: parts 1–6 of the guide. Out of scope: PID quantitation and MS CSF markers.
- **Every fixed number is a P136 reviewer question** (FR-018). The source is a secondary summary that was not checked against primary guidelines.
